SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000910680-22-000005
Filing Date
2022-07-12
Accepted
2022-07-12 13:24:39
Documents
1
Group Members
THOMAS VON KOCH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13ga-07082022.htm SC 13G/A 44827
  Complete submission text file 0000910680-22-000005.txt   46424
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Subject) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90788 | Film No.: 221078822
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EQT PARTNERS AB BOX 16509 STOCKHOLM V7 103 27
Business Address C/O EQT PARTNERS AB BOX 16509 STOCKHOLM V7 103 27 46 70 514 21 94
TomEnterprise AB (Filed by) CIK: 0001887435 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A